Skip to main content
Log in

Value of the Congenital Hypertrophy of the Retinal Pigment Epithelium in the Diagnosis of Familial Adenomatous Polyposis

  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Background: Several kinds of congenital hypertrophy of the retinal pigment epithelium (CHRPE) have been described in patients with familial adenomatous polyposis (FAP). This study aims to assess which properties of CHRPE better predict FAP and investigate whether a relationship exists between specific CHRPE characteristics and FAP variants. Methods: We examined 286 subjects, Group I — patients with FAP plus individuals “at risk”; n = 173; Group II — controls n = 113. Retinal lesions were classified in five types (A–E) and different characteristics (distribution, number, shape, size, pigmentation and site) were evaluated. Results: The most common lesions in affected subjects were types A–D (83.4%) whilst in the “at risk” and control groups were type E. Greater numbers of lesions and bilateral distribution occurred more frequently among affected subjects than in other participants (p < 0.001). Large lesions with mixed pigmentation were associated with polyposis (p > 0.5). Controls had solitary CHRPE lesions (3.5%) and types C and E lesions (23%). The cumulative sensitivities and specificities of CHRPE were 42 and 97%, respectively. CHRPE was most common among those with classical FAP, but no specific characteristic was associated with any particular FAP variant. Conclusions: Pigmented fundal lesions are highly pleomorphic and represent the variable expression of a common genetic defect of growth regulation. No association was found between CHRPE characteristics and specific FAP variants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rustgi AK. Hereditary gastrointestinal polyposis and nonpolyposis syndromes. N Engl J Med 1994; 331: 1694–1702.

    Article  CAS  PubMed  Google Scholar 

  2. Campbell WJ, Spence RAJ, Park TG. Familial adenomatous polyposis. Br J Surg 1994; 81: 1722–1733.

    CAS  PubMed  Google Scholar 

  3. Dean PA. Hereditary intestinal polyposis syndromes. Rev Gastroenterol Mex 1996; 61: 100–111.

    CAS  PubMed  Google Scholar 

  4. Herrera L, Kakati S, Gibas L, Pietrzak E, Sandberg AA. Gardner syndrome in a man with an interstitial deletion of 5q. Am J Hum Genet 1986; 25: 473–476.

    CAS  Google Scholar 

  5. Leppert M, Dobbs M, Scambler P, O'Connell, Nakamura Y, Stauffer D, et al. The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 1987; 238: 1411–1413.

    CAS  PubMed  Google Scholar 

  6. Spiro L, Otterud B, Stauffer D, Lynch H, Lynch P, Watson P, et al. Linkage of a variant or attenuated form of adenomatous polyposis coli to adenomatous polyposis coli (APC) locus. Am J Hum Genet 1992; 51: 92–100.

    Google Scholar 

  7. Giardiello FM, Brensinger JD, Luce MC, Petersen GM, Cayouette MC, Krush AJ, et al. Phenotypic expression of disease in families that have mutations in the 5″ region of the adenomatous polyposis coli gen. Ann Intern Med 1997; 126: 514–519.

    CAS  PubMed  Google Scholar 

  8. Lynch HT, Smyrk T, McGinn T, Lanspa S, Cavalieri J, Lynch J, et al. Attenuated familial adenomatous polyposis (AFAP): aphenotypically and genotypically distinctive variant of FAP. Cancer 1995; 76: 2427–2433.

    CAS  PubMed  Google Scholar 

  9. Foulkes WD. A tale of four syndromes: familial adenomatous polyposis, Gardner syndrome, attenuated APC and Turcot syndrome. Q J Med 1995; 88: 853–863.

    CAS  Google Scholar 

  10. Parks TG. Extracolonic manifestations associated with familial adenomatous polyposis. Ann R Coll Surg Engl 1190; 72: 181–184.

  11. Harned RK, Buck JL, Olmsted WW, Moser RP, Ros PR Extracolonic manifestations of the familial adenomatous polyposis syndromes. AJR 1991; 156: 481–485.

    CAS  PubMed  Google Scholar 

  12. Jagelman DG. Extra-colonic manifestations of familial adenomatous polyposis. Oncology 1991; 5: 23–27.

    CAS  PubMed  Google Scholar 

  13. Cabot RC. Case records of Massachusetts General Hospi-tal: case 21061. N Engl J Med 1935; 212: 263–267.

    Google Scholar 

  14. Blair NP, Trempe CL. Hypertrophy of the retinal pigment epithelium associated with Gardner's syndrome. Am J Ophthalmol 1980; 90: 661–667.

    CAS  PubMed  Google Scholar 

  15. Lewis RA, Crowder WE, Eierman LA, Nussbaum RL, Ferrrell 1RE. The Gardner syndrome: significance of ocular features. Ophthalmology 1984: 91: 916–925.

    CAS  PubMed  Google Scholar 

  16. Traboulsi K, Krush AJ, Gardner EJ, Booker SV, Offerhaus GJA, Yardley JH, et al. Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome. N Engl J Med 1987; 316: 661–667.

    CAS  PubMed  Google Scholar 

  17. Díaz-Llopis M, Menezo JL. Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyp-osis. Arch Ophthalmol 1988; 106: 412–413.

    PubMed  Google Scholar 

  18. Baker RH, Heinemann MH, Miller HH, De Cose JJ. Hyperpigmented lesions of the retinal pigment epithelium in familial adenomatous polyposis. Am J Med Genet 1988; 31: 427–435.

    Article  CAS  PubMed  Google Scholar 

  19. Romania A, Zakov ZN, McGannon E, Schroeder T, Heyden F, Jagelman DG. Congenital hypertrophy of the retinal pigment epithelium and familial adenomatous pol-yposis. Ophthalmology 1989; 96: 879–884.

    CAS  PubMed  Google Scholar 

  20. Morton DG, Gibson J, Macdonald F, Brown R, Haydon J, Cullen R, et al. Role of congenital hypertrophy of the retinal pigment epithelium in the predictive diagnosis of familial adenomatous polyposis. Br J Surg 1992; 79: 689–693.

    CAS  PubMed  Google Scholar 

  21. Berk T, Cohen Z, McLeod RS, Parker JA. Congenital hypertrophy of the retinal pigment epithelium as a marker for familial adenomatous polyposis. Dis Colon Rectum 1988; 31: 253–257.

    CAS  PubMed  Google Scholar 

  22. Traboulsi EI, Maumenee IH, Krush AJ, Giardiello FM, Levin LS, Hamilton SR. Pigmented ocular fundus lesions in the inherited gastrointestinal polyposis syndromes and in hereditary nonpolyposis colorectal cancer. Ophthalmology 1988; 95: 964–969.

    CAS  PubMed  Google Scholar 

  23. Polkinghorne PJ, Ritchie S, Neale K, Schoeppner G, Thomson JPS, Jay BS. Pigmented lesions of the retinal pigmented epithelium and familial adenomatous polyposis. Eye 1990; 4: 216–221.

    PubMed  Google Scholar 

  24. Iwama T, Mishima Y, Okamoto N, Inoue J. Association of congenital hypertrophy of the retinal pigment epithelium with familial adenomatous polyposis. Br J Surg 1990; 77: 273–276.

    CAS  PubMed  Google Scholar 

  25. Bussey HJR. Historical developments in familial polyposis coli. Semin Surg Oncol 1987; 3:67–70.

    CAS  PubMed  Google Scholar 

  26. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, et al. Identification and characterization of the familial adenomatous polyposis coli gen. Cell 1991; 66: 589–600.

    Article  CAS  PubMed  Google Scholar 

  27. Nagase H, Nakamura Y. Mutations of the APC (adeno-matous polyposis coli) gen. Hum Mutat 1993; 2: 424–435.

    Article  Google Scholar 

  28. Utsunomiya J, Nakamura T. The occult osteomatous changes in the mandible in patients with familial adeno-matous coli. Br J Surg 1975; 62: 45–51.

    CAS  PubMed  Google Scholar 

  29. Offerhaus GJA, Levin LS, Giardiello FM, Krush AJ, Welsh SB, Booker SV, et al. Occult radio-opaque jaw lesions in familial adenomatous polyposis coli and hereditary nonpo-lyposis colorectal cancer. Gastroenterology 1987; 93: 490–497.

    CAS  PubMed  Google Scholar 

  30. Heyen F, Jagelman DG, Romania A, Zakov ZN, Lavery IC, Fazio VW, et al. Predictive value of congenital hypertrophy of the retinal pigment epithelium as a clinical marker for familial adenomatous polyposis. Dis Colon Rectum 1990; 33: 1003–1008.

    Article  CAS  PubMed  Google Scholar 

  31. Parker JA, Berk T, Bapat BV. Familial variation in retinal pigmentation in adenomatous polyposis. Can J Ophthalmol 1995; 30: 138–141.

    CAS  PubMed  Google Scholar 

  32. Tiret A, Taiel-Sartral M, Tiret E, Laroche L. Diagnostic value of fundus examination in familial adenomatous polyposis. Br J Ophthalmol 1997; 81: 755–758.

    CAS  PubMed  Google Scholar 

  33. Tiret A, Parc C. Fundus lesions of the adenomatous polyposis. Curr Opin Ophthalmol 1999; 10: 168–172.

    Article  CAS  PubMed  Google Scholar 

  34. Parker JA, Kalnins VI, Deck JHN, Cohen Z, Berk T, Cullen JB, et al. Histopathological features of congenital fundus lesions in familial adenomatous polyposis. Can J Ophthalmol 1990; 25: 159–163.

    CAS  PubMed  Google Scholar 

  35. Traboulsi EI, Murphy SF, De la Cruz Z, Maumenee IH, Green WR. A clinicopathologic study of the eyes in familial adenomatous polyposis with extracolonic manifestations (Gardneŕs syndrome). Am J Ophthalmol 1990; 110: 550–561.

    CAS  PubMed  Google Scholar 

  36. Kasner L, Traboulsi EI, De la Cruz Z, Green WR. A histopathologic study of the pigmented fundus lesions in familial adenomatous polyposis. Retina 1992; 12: 35–42.

    CAS  PubMed  Google Scholar 

  37. Moore AT, Maher ER, Koch DJ, Charles SJ. Incidence and significance of congenital hypertrophy of the retinal pig-ment epithelium (CHRPE) in familial adenomatous polyp-osis coli (FAPC). Ophthalmic Paed Genet 1992; 13: 67–71.

    CAS  Google Scholar 

  38. Olea JL, Mateos JM, Llompart A, Obrador A. Frequency of congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis. Acta Ophthalmol Scand 1996; 74: 48–50.

    CAS  PubMed  Google Scholar 

  39. Olschwang S, Tiret A, Lauren-Puig P, Murelis M, Parc R, Thomas G. Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 1993; 75: 959–968.

    Article  CAS  PubMed  Google Scholar 

  40. Baba S, Tsuchiya M, Watanabe I, Machida H. Importance of retinal pigmentation as a subclinical marker in familial adenomatous polyposis. Dis Colon Rectum 1990; 33: 660–665.

    CAS  PubMed  Google Scholar 

  41. Heinemann MH, Baker RH, Miller HH, DeCosse JJ. Familial polyposis coli: the spectrum of ocular and other extracolonic manifestations. Graefe_s Arch Clin Exp Oph-thalmol 1991; 229: 213–218.

    CAS  Google Scholar 

  42. Bertario L, Bandello F, Rossetti C, Sala P, Fortini E, Spinelli P, et al. Congenital hypertrophy of retinal pigment epithelium (CHRPE) as a marker for familial adenomatous polyposis (FAP). Eur J Cancer 1993; 2: 69–75.

    CAS  Google Scholar 

  43. Romania A, Zakov ZN, Church JM, Jagelman DG. Retinal pigment epithelium lesions as a biomarker of disease in patients with familial adenomatous polyposis: a fellow-up report. Ophthalmology 1992; 99: 911–913.

    CAS  PubMed  Google Scholar 

  44. Traboulsi EI, Maumenee IH, Krush AJ, Alcorn D, Giardiello FM, Burt RW, et al. Congenital hypertrophy of the retinal pigment epithelium predicts colorectal polyp-osis in Gardner's syndrome. Arch Ophthalmol 1990; 108: 525–526.

    CAS  PubMed  Google Scholar 

  45. Szwarcberg J, Limacher JM, Fricker JP, Flament J. L'hypertrophie congénitale de l′épithélium pigmenté rétinien: un marqueur de la polypose adénomateuse familiale. J Fr Ophthalmol 1999; 22: 364–370.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rosario Touriño.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Touriño, R., Conde-Freire, R., Cabezas-Agrícola, J.M. et al. Value of the Congenital Hypertrophy of the Retinal Pigment Epithelium in the Diagnosis of Familial Adenomatous Polyposis. Int Ophthalmol 25, 101–112 (2004). https://doi.org/10.1023/B:INTE.0000031739.62559.ac

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:INTE.0000031739.62559.ac

Navigation